You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukopenia

Showing 26 - 50 of 3,707
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,

Active, not recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Atlanta, Georgia
  • +9 more
Oct 12, 2022

Renal Transplant Trial in Toledo (Arm 1 Everolimus/Reduced dose tacrolimus)

Completed
Has Results
  • Renal Transplant
  • Arm 1 Everolimus/Reduced dose tacrolimus
  • Toledo, Ohio
    University of Toledo, Health Science Campus
May 2, 2022

Breast Tumors Trial in Shanghai (Epirubicin, Docetaxel, cyclophosphamide)

Completed
  • Breast Neoplasms
  • Shanghai, Shanghai, China
    Ruijin Hospital
Oct 26, 2022

Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

Not yet recruiting
  • Urinary Bladder Neoplasms
    • (no location specified)
    Feb 14, 2023

    Proliferative Glomerulonephritis With Monoclonal IgG Deposits Trial in Rochester (Daratumumab)

    Not yet recruiting
    • Proliferative Glomerulonephritis With Monoclonal IgG Deposits
    • Rochester, Minnesota
      Mayo Clinic Minnesota
    Dec 8, 2022

    Lupus Erythematosus, Systemic Trial (Cenerimod, Placebo)

    Not yet recruiting
    • Lupus Erythematosus, Systemic
    • (no location specified)
    Jan 3, 2023

    Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

    Enrolling by invitation
    • Malignant Melanomas
    • Recombinant Human Adenovirus Type 5 Injection
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
    Jul 7, 2023

    Lupus Erythematosus, Systemic Trial in Baytown, Houston (Cenerimod, Placebo)

    Recruiting
    • Lupus Erythematosus, Systemic
    • Baytown, Texas
    • +1 more
    Dec 22, 2022

    Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy Trial in Moscow (mycophenolate mofetil 2 g per day,

    Recruiting
    • Lymphocytic Myocarditis (Disorder)
    • +4 more
    • mycophenolate mofetil 2 g per day
    • azathioprine of 150 [75; 150] mg per day
    • Moscow, Bol'shaya Pirogovskaya Street 6, 1 Building ,, Russian Federation
      I.M. Sechenov First Moscow State Medical University (Sechenov Un
    Feb 2, 2022

    Infection, Transplant;Failure,Kidney Trial in San Francisco (Mycophenolate Mofetil)

    Withdrawn
    • Infection
    • Transplant;Failure,Kidney
    • Mycophenolate Mofetil
    • San Francisco, California
      University of California, San Francisco
    May 2, 2022

    Locally Advanced Intrahepatic Cholangiocarcinoma, Oligometastatic Intrahepatic Cholangiocarcinoma, Stage III Intrahepatic

    Not yet recruiting
    • Locally Advanced Intrahepatic Cholangiocarcinoma
    • +4 more
    • Angiography
    • +8 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Sep 22, 2023

    Carbapenem-Resistant Enterobacteriaceae Infection, KPC, Gram-Negative Bacterial Infections Trial in Charlotte

    Recruiting
    • Carbapenem-Resistant Enterobacteriaceae Infection
    • +3 more
    • Charlotte, North Carolina
      Carolinas Medical Center
    Jun 16, 2022

    Kidney Diseases, Kidney Transplant Infection, Kidney Transplant; Complications Trial in Essen (Extracorporal therapy)

    Not yet recruiting
    • Kidney Diseases
    • +2 more
    • Extracorporal therapy
    • Essen, Germany
      University Hospital Essen
    Dec 16, 2021

    Dengue Trial in Syracuse (Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC))

    Completed
    • Dengue
    • Dengue virus 3 Live Virus Human Challenge (DENV-3-LVHC)
    • Syracuse, New York
      State University of New York, Upstate Medical University (SUNY-U
    Jun 10, 2022

    Ventilator Associated Pneumonia Trial in Acquaviva Delle Fonti, Bari (LactoLevure, Placebo)

    Not yet recruiting
    • Ventilator Associated Pneumonia
    • LactoLevure
    • Placebo
    • Acquaviva Delle Fonti, BA, Italy
    • +1 more
    Oct 22, 2023

    Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • +3 more
    • Guangzhou, Guangdong, China
      Department of Radiation Oncology, Sun Yat-Sen University Cancer
    Mar 10, 2023

    Glioblastoma Multiforme Trial in Edmonton (Tamoxifen, Etoposide)

    Recruiting
    • Glioblastoma Multiforme
    • Edmonton, Alberta, Canada
      Cross Cancer Institute
    Mar 28, 2022

    Sepsis, Hemodynamic Instability, Bacterial Infections Trial in Singapore (Therapeutic Drug Monitoring (TDM))

    Recruiting
    • Sepsis
    • +4 more
    • Therapeutic Drug Monitoring (TDM)
    • Singapore, Singapore
      Singapore General Hospital
    Jul 17, 2023

    Re-EValuating Inhibition of Stress Erosions - COVID-19 Cohort

    Recruiting
    • COVID-19
    • GastroIntestinal Bleeding
    • Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial (NCT03374800)
    • Hamilton, Ontario, Canada
      St Joseph's Healthcare Hamilton
    Feb 6, 2023

    Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • Beijing, Beijing, China
      Department of Radiation Oncology, Cancer Institute and Hospital,
    Jul 12, 2023

    Kidney Cancer Trial in New York (recombinant interferon alfa, tretinoin liposome)

    Completed
    Has Results
    • Kidney Cancer
    • recombinant interferon alfa
    • tretinoin liposome
    • New York, New York
    • +1 more
    Mar 17, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Baltimore, Maryland
      The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Sep 23, 2022

    Inflammatory Response, Cardiac Disease Trial (Colchicine 0.5 MG, Placebo)

    Not yet recruiting
    • Inflammatory Response
    • Cardiac Disease
    • Colchicine 0.5 MG
    • Placebo
    • (no location specified)
    Nov 1, 2023

    Hypersplenism Trial in Zagazig (partial splenic artery embolization)

    Completed
    • Hypersplenism
    • partial splenic artery embolization
    • Zagazig, Egypt
      Faculty of medicine, Zagazig university
    Jun 30, 2022

    Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)

    Recruiting
    • Immune Thrombocytopenia
    • Bruton Tyrosine Kinase
    • Beijing, Beijing, China
      Peking University Insititute of Hematology, Peking University Pe
    Mar 6, 2022